Himalaya Nutravedics India Limited
ClosedSMEHealthcare · BSE
Himalaya Nutravedics India Ltd is engaged in the manufacturing, marketing, and distribution of Ayurvedic and nutraceutical formulations in India, along with offering third-party contract manufacturing services for other companies in this space. The company has a diversified product portfolio comprising classical Ayurvedic formulations based on traditional texts, proprietary Ayurvedic products, and nutraceutical supplements, available in various dosage forms such as soft gelatin capsules, hard gelatin capsules, tablets, liquid orals, and medicated oils. It operates on a hybrid business model that balances its own branded products with contract manufacturing, supported by an integrated in-house manufacturing facility located in Hyderabad, Telangana. As of September 2025, its products are distributed across multiple states including Telangana, Andhra Pradesh, Kerala, Gujarat, and Uttar Pradesh, with offerings catering to a wide range of wellness segments such as digestive health, immunity, metabolic health, joint care, reproductive health, respiratory wellness, pain management, and overall well-being, aligned with regulatory standards.
Price Band
₹100 – ₹106
Issue Size
₹249.96 L Cr
Lot Size
1200 shares
GMP
—
Est. Listing
₹106
at current GMP
Subscribed
2.33x
overall
Open
22 Sep 2026
Close
24 Sep 2026
Allotment
25 Sep 2026
Refund
26 Sep 2026
Demat Credit
27 Sep 2026
Listing
29 Sep 2026
Last updated 2 days ago
Live Grey Market Premium
Himalaya Nutravedics India Limited GMP Today
Last updated: 25 Sept 2026
Current Premium
₹00.0%
Issue Price (Upper)
₹106
Band: ₹100 – ₹106
Estimated Listing Price
₹106
Upper price + GMP
Lot Size
1200 shares
Min investment ₹1,27,200
Estimated Profit / Lot
₹0
1200 × ₹0
Himalaya Nutravedics India Limited GMP Historical Trend
GMP History
Grey Market Premium trend
—
▲ 0 today
Updated 1 minute ago
Estimated Listing Price
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 27 Sep 2026 | — | 0.0% | ₹106 |
| 26 Sep 2026 | — | 0.0% | ₹106 |
| 25 Sep 2026 | — | 0.0% | ₹106 |
GMP is unofficial market data. Not a guarantee of listing performance.
About Himalaya Nutravedics India Limited Public Issue & Market Profile
Himalaya Nutravedics India Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹24,99,600 Crores. The shares are offered at a price band of ₹100 to ₹106 per equity share on BSE. Currently, market analysts recommend evaluating the company's financial valuation, price-to-earnings (P/E) multiple, and peer comparison prior to submitting bids.
Public Issue & Pricing Context:
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Basis of Allotment & Listing Timeline:
Following the close of bidding on 2026-09-24, the basis of allotment is scheduled to be finalized on 2026-09-25. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Kfin Technologies Limited) or the BSE allotment checking window.
Frequently Asked Questions
What is Himalaya Nutravedics India Limited IPO GMP today?
The latest grey market premium for Himalaya Nutravedics India Limited IPO is ₹0, which indicates an expected listing price of ₹106.
What does Kostak Rate and Sauda mean in IPO GMP?
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
Is Grey Market Premium officially recognized?
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.